Experimental vaccine shows promise in delaying the return of aggressive brain tumor
The vaccine was shown to nearly double the survival time in a trial of 63 patients. Researchers now hope to confirm the findings in a larger trial.
This underappreciated cybersecurity stock could rally more than 35%, Morgan Stanley says
Despite recent execution blunders, Morgan Stanley believes SentinelOne shares are now mispriced by Wall Street.
This software stock can pop nearly 20% thanks to its early-mover advantage in A.I., Wolfe Research says
Analyst Alex Zukin raised his rating on shares to outperform from peer perform.
Amazon shares can rally nearly 25% as retail margins improve, Bank of America says
The bank hiked its price target on Amazon shares to $154 from $139, citing an improving outlook on retail margins.
JPMorgan upgrades Carnival as momentum for the cruise industry grows
Carnival’s post-pandemic recovery is not just a short-term boom, but an indication of more sustainable business strength, says JPMorgan.
Horses die in consecutive races at Belmont Park, following history-making event
Horses die in consecutive races at Belmont Park, following history-making event.
Illumina announces CEO transition plan as Francis deSouza resigns
Illumina announced its board of directors has accepted the resignation of CEO Francis deSouza Sunday.
Now Boarding: Airlines are bringing back the jumbo jet (sort of)
On this episode of “Now Boarding,” CNBC discusses the rise, fall and recent revival of jumbo jets.
Tesla is far and away the most overbought stock on Wall Street. Here are the others
One widely used metric called the ‘relative strength index’ showed investors this week piled into the electric vehicle maker.
Trump delivers fiery post-indictment speech: ‘They’re coming after you’
In his first remarks being indicted in the federal classified documents probe, he warned Georgia activists that the “deep state” was coming for them, too.
